Publication | Closed Access

Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells with a myeloablative regimen for refractory/relapsed hematologic malignancy

Regenerative MedicineHematological MalignancyMyeloablative RegimenMedicineMalignant Blood DisorderHematologyRefractory/relapsed Hematologic MalignancyMyeloid NeoplasiaCell BiologyRadiation OncologyStem CellsCell TransplantationHealth Sciences